Figures & data
Figure 1 Relation of frequency of OHSS and the use of recombinant hFSH.
Notes: r-hFSH was introduced into the market in Germany in 1998. Data from the German IVF-Registry – D·I·R; www.deutsches-ivf-register.de.Citation33
Abbreviations: FSH, follicle stimulating hormone; OHSS, ovarian hyperstimulation syndrome; r-hFSH, recombinant-human follicle stimulating hormone.
Abbreviations: FSH, follicle stimulating hormone; OHSS, ovarian hyperstimulation syndrome; r-hFSH, recombinant-human follicle stimulating hormone.
![Figure 1 Relation of frequency of OHSS and the use of recombinant hFSH.](/cms/asset/5a9123c9-e4ab-4440-bd82-03f0502bf00f/dtcr_a_64222_f0001_c.jpg)
Figure 2 Significant milestones in gonadotropin development.
Notes: The more the gonadotropins are purified, the higher is the specific activity and consistency, providing a greater safety for the patients. In green: urinary products still on the market; in blue: recombinant gonadotropins up to filled by mass; in black: newer recombinant preparations and the future.
Abbreviations: FbM, filled by mass; hp, highly purified; Gn, gonadotropin; rec-h(FSH+LH), fixed combination of recombinant FSH and recombinant LH in the ratio 2:1: Pergoveris® (Merck Senoro, Darmstadt, Germany); FSH, follicle stimulating hormone; LH, leutinizing hormone; hMG, urinary human menopausal gonadotropin; hCG, human chorionic gonadotropin; PMSG, pregnant mare serum gonadotropin; rec, recombinant.
Abbreviations: FbM, filled by mass; hp, highly purified; Gn, gonadotropin; rec-h(FSH+LH), fixed combination of recombinant FSH and recombinant LH in the ratio 2:1: Pergoveris® (Merck Senoro, Darmstadt, Germany); FSH, follicle stimulating hormone; LH, leutinizing hormone; hMG, urinary human menopausal gonadotropin; hCG, human chorionic gonadotropin; PMSG, pregnant mare serum gonadotropin; rec, recombinant.
![Figure 2 Significant milestones in gonadotropin development.](/cms/asset/4584b39e-1dad-4b3a-bf8c-e644512ee462/dtcr_a_64222_f0002_c.jpg)